Lazard Asset Management
PROK icon

Lazard Asset Management’s ProKidney PROK Stock Holding History

Lazard Asset Management’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-9,538
Closed -$16K – 2308
2023
Q4 		$16K Buy
9,538
+7,119
+294% +$15.3K ﹤0.01% 2071
2023
Q3 		$10K Sell
2,419
-358
-13% -$3.43K ﹤0.01% 2145
2023
Q2 		$31K Buy
+2,777
New +$29.6K ﹤0.01% 1985

Other funds holding PROK

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management's PROK Position: Q1 2024 in Review

Lazard Asset Management sold out of ProKidney (PROK) in Q1 2024, closing a stake of 9,538 shares — an estimated $16K sold.

Lazard Asset Management first reported a position in PROK in Q2 2023 and held it in 3 quarters. The position peaked at $31K in Q2 2023. 55 funds tracked by Wall St. Rank hold PROK as of Q1 2024.

  • Lazard Asset Management reported no remaining ProKidney position as of Q1 2024 after selling out during the quarter.
  • Lazard Asset Management sold 9,538 ProKidney shares in Q1 2024, an estimated $16K.
  • Lazard Asset Management first reported a position in ProKidney in Q2 2023 and held it in 3 quarters.
  • Lazard Asset Management's ProKidney position peaked at $31K in Q2 2023.
  • 55 funds tracked by Wall St. Rank held ProKidney as of Q1 2024.

Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.